CV N. Vlachos

Curriculum Vitae

Nikos Vlahos M.D.FACOG

Assistant Professor of Gynecology and Obstetrics

Aretaeion University Hospital

Diplomate of the American Board of Obstetrics and Gynecology

Diplomate of the American Board of Reproductive Medicine

1 / 25

CV N. Vlachos

e-mail:   nikosvlahos@med.uoa.gr

Current Position: Assistant Professor,

2nd Department of Obstetrics and Gynecology,

Athens Medical School

Aretaieion Hospital, Athens, Greece.

July 2000- September 2004 Assistant Professor, Gynecology and Obstetrics,

Division of Reproductive Endocrinology,

2 / 25

CV N. Vlachos

The Johns Hopkins University, School of Medicine

July 1999 to June 2000:                                                  Instructor, Gynecology and Obstetrics,

Division of Reproductive Endocrinology,

The Johns Hopkins University, School of Medicine

July 1997 to June 1999: Fellow in Reproductive Endocrinology

Division of Reproductive Endocrinology,

Department of Gynecology and Obstetrics,

The Johns Hopkins University, School of Medicine.

July 1996-June 1997: Administrative Chief Resident, in Obstetrics and Gynecology,Brookdale University Hospital,

Brooklyn, New York, USA

3 / 25

CV N. Vlachos

July 1993-June 1996: Resident in Obstetrics and Gynecology

Brookdale University Hospital,

Brooklyn, New York, USA

Education: M.D. University of Athens Medical School, Athens, Greece.

June 1989

Grade: ARISTA (Excellent)

B.S: Lyceion.  Papagou

Athens, Greece 1983

4 / 25

CV N. Vlachos

Awards and Honors:

1996: Award for Excellence in Endoscopic Procedures American Association ofGynecologic Laparoscopists

1996: Lilian Voudouri Award:

For excellence in academic studies

1997: Galloway Fellowship Award

Gynecological Oncology

Memorial Sloan Kettering Cancer Center

5 / 25

CV N. Vlachos

Certifications: Fellow of   the American Board of Obstetricians and Gynecologists

Diplomate of   the American Board of Obstetricians and Gynecologists

Diplomate of the American Society for Reproductive Medicine

Medicine Ptycheion Iatrikes: Athens Medical School, Valedictorian.  Final Cumulative Score:ARISTA (Excellent)

ECFMG certificate # 0-450-010-4

FLEX certificate # 651204008

6 / 25

CV N. Vlachos

Clinical Funded Research:

Principal investigator:

AKZO NOBEL: Protocol # 01-01-26-06 ($75,000 + 65,000)

Endometrial Luteal phase characteristics and luteal phase support in controlled ovarianhyperstimulation

protocols with Gonadotropin Releasing Hormone Antagonists

Co-Investigator:

Organon Co. Protocol # 053-004

Open labeled, randomized multicenter study to assess the efficacy and safety of a Follistimsolution

7 / 25

CV N. Vlachos

formulation compared to a Freeze-dried cake formulation , both  administered subcutaneously

for the induction of ovulation in clomiphene resistant subjects with chronic anovulation ( WHOgroup II).

Parke-Davis Co. Protocol # 97071603.

Urinary excretion of Deoxypyridinoline Crosslinks and N-telopeptides in healthy

perimenopausal patients: The effect of low-dose oral contraceptives.

Professional Organizations: · American College of Obstetricians and Gynecologists

- · American Association of Gynecologic Laparoscopists - · American Society for Reproductive Medicine - American Association of Laparoendoscopic Surgeons

- · European Society for Human Reproduction and Embryology - · The Johns Hopkins Medical and Surgical Association - · The Kelly Society of the Johns Hopkins Hospital

8 / 25

CV N. Vlachos

Publications:

Abstracts:

1)            Lambrou, N., Rosanfekr, D., Vlahos, NP., Phelps, JY. “Accuracy and IntraexaminerVariability of Simulated

Cervical Dilatation and Effacement Measurements.” The 47th American College ofObstetricians

and Gynecologists (ACOG) Annual Meeting,   New Orleans, LA.  May 20-24, 1998, (Oralpresentation)

2)            Vlahos, N.P., Phelps, J.Y., Zacur, H.A., Aleem, F. “Changes in the Fallopian TubeCirculation after

Treatment of Ectopic Pregnancy with Methotrexate.” The 14thAnnual Meeting of theEuropean Society for

9 / 25

CV N. Vlachos

the Human Reproduction and Embryology, (ESHRE) Göteborg, Sweden.  June 20-24, 1998, (Oral presentation)

3)            Fauzia, M., Phelps, J.Y., Vlahos, N.P., Figueira-Armada, L., Garcia, J.E. “BaselineFollicle Stimulating

Hormone: Luteinizing Hormone Ratios are not Predictive of Pregnancy Outcome andOvarian Response to

Controlled Ovarian Hyperstimulation.” The 54th Annual Meeting of the American Society forReproductive Medicine.

San Francisco, CA. October 4-8 1998, (Oral presentation)

4)            Phelps, J.Y., Figeira, Armada L., Vlahos, N.P., Zacur, H.A., Garcia, J.E. “LowMid-Follicular Serum: Luteinizing

Hormone Concentrations are associated with Significantly Lower EstradiolConcentrations in Patients Undergoing

Controlled Ovarian Hyperstimulation for IVF.” The 37th Annual ACOG Conference. The 20th

Annual Armed Forces District

10 / 25

CV N. Vlachos

Meeting.  Kissimmee, FL.  October 18-21, 1998,  (Oral presentation)

5)            Vlahos, N.P., Fauzia, M., Whelan, J., Wallach, E.E.,  Garcia, J.E. “Correlation of Infertility Etiology to IVF Success Rates.

” The 4th International Congress:  “The young woman at the rise of the 21st century:Gynecological and Reproductive Issues in

Health and Disease.” November 18-21,1998 Athens, Greece.  (Oral presentation)

6)           Vlahos, N.P., Dragasic, K.G., Whelan, J., Wallach, E.E. “Subsequent Developmentof Cervical Intraepithelial Pathology in Patients with Atypical Squamous Cells ofUndetermined Significance.”The 4th

International Congress: “The young woman at the rise of the 21st

century: Gynecological and Reproductive Issues in Health and Disease.”  November18-21,1998  Athens,  Greece.  (Oral presentation)

7)            Vlahos, N.P., Bugg, E.M., Shamblott, M.J., Garcia, J.E., Gearhart, H.A., Zacur, H.A. “Localization of the Prolactin Receptor in Luteinized Human Granulosa Cells.”Late breaking news in research and technology, 55th

11 / 25

CV N. Vlachos

Annual Meeting of The American Society for Reproductive Medicine.  September 25-30, 1999:Toronto, Canada.  (Oral presentation)

8)            Figueira, L., Vlahos, N.P., Phelps, J.Y., Zacur, H.A., Garcia, J.E. “MidfollicularSerum LH Concentrations do not Predict Pregnancy Outcome in Controlled OvarianHyperstimulation and IVF.”The 55th

Annual Meeting of the American Society for Reproductive Medicine: Toronto, Canada:September 25-30, 1999,  (Poster).

9)            Vlahos, N.P., Dragisic, K.G., Wallach, E.E., Byrroughs, F.H, Fluck, S., Rosenthal, D.L.“Clinical Significance of the Qualification of Atypical Squamous

Cells of Undetermined Significance: An Analysis Based on Histologic Diagnoses.”District IV annual meeting of the American College of Obstetricians and Gynecologists. Fajardo, Puerto Rico: October 15-19, 1999, (Oral presentation).

10)          Vlahos, N.P, Figueira, L., Wallach, E.E., Zacur H.A., Garcia, J.E. “Factors thatPredict the Outcome of a Controlled Ovarian Hyperstimulation Protocol for IVF.”District IV annual meeting of the American College of Obstetricians and Gynecologists. Fajardo,Puerto Rico: October 15-19 1999, (Poster).

12 / 25

CV N. Vlachos

11)          El-Minawi, A.M., Vlahos, N.P., Garcia, J.E. “Follicular Growth during ClomipheneCitrate Ovarian Stimulation for IUI.”District IV annual meeting of the American College of Obstetricians and Gynecologists; Fajardo,Puerto Rico: October 15-19 1999, (Poster).

12)          Trevino N, Hermann J, Wehrum M,  Vlahos NP, Robinson R, Phelps JY “Openlaparoscopy as an alternative to laparotomy for the ectopic pregnancies in the presenceof an extensive hemoperitoneum.” The 18th

International Meeting of Laparoendoscopic Surgeons.  December 4-7, 1999.  New York, NY. (Oral presentation).

13)          Vlahos NP, Bugg EM, Shamblott MJ, Phelps JY, Garcia JE, Gearhart JD, Zacur HA “Prolactin receptors and Prolactin receptor Gene expression in Luteinized Hymangranulosa cells.”47th

Annual meeting of the Society for gynecologic Investigation March 22-25 2000, Chicago IL

14)          Posada M.N., Vlahos N.P., Whelan J.G, Murphy J.M., Zacur H.A, Wallach E.E.,Garcia J.E. “Four days of leuprolide acetate preventspremature luteinization in flare-up stimulation protocol.” 16th

Annual meeting of the European Society for Reproduction and Embryology (ESHRE), June25-28 2000. Bologna, Italy

13 / 25

CV N. Vlachos

15)        Bracero N.J., Jurema M.W., Posada M.N., Whelan J.G., Garcia J.E.,. Vlahos N.P.“Triggering ovulation with leuprolide acetate (LA) instead of human chorionicgonadotropin (hCG) after the use of ganirelix for in vitro fertilization-embryo transfer(IVF-ET) does not compromise cycle out-come and may prevent ovarian hyperstimulationsyndrome. The 57th

Annual Meeting of the American Society for Reproductive Medicine: October 20-25,2001Orlando, Florida

16)        Jurema M.W., Posada M.N., Bracero N.J., Vlahos N.P., Garcia J.E.. “Beneficial useof ganirelix in controlled ovarian hyperstimulation (COH) cycles in older womenundergoing in vitro fertilization (IVF).”The 57th

Annual Meeting of the American Society for Reproductive Medicine: October 20-25,2001Orlando, Florida.

17)        Posada M.N.,. Jurema M.W,. Vlahos N.P,. Bracero N.J, Wallach E.E., Garcia J.E.. “Should women with poor prognostic factors for controlled ovarian hyperstimulationundergo in vitro fertilization (COH-IVF) using ganirelix acetate?”The 57th

Annual Meeting of the American Society for Reproductive Medicine: October 20-25,2001Orlando, Florida.

14 / 25

CV N. Vlachos

18)          Bracero N, Jurema M, Vlahos N, Kolp L, Garcia J. “Polycystic ovarian syndrome(PCOS) patients have a favorable response to ganirelix acetate during controlled ovarianhyperstimulation (COH) for in vitro fertilization (IVF)- embryo transfer (ET).”The 58th

Annual meeting of the American Society for Reproductive Medicine: October 12-17,2002Seattle, Washington.

19)          Bankowski B, Zhao Y, Zacur H, Wallach E, Garcia J. Vlahos N. “ High pregnancyrates using GnRH antagonists for oocyte donation”19th

Annual meeting of the European Society for Reproduction and Embryology (ESHRE), June29-July 2nd

2003. Madrid, Spain.

20)          Coker L, Lawler C, Zhao Y, Bankowski B, Wallach E,Vlahos NP. “Follicular diameterand Hcg administration do not affect pregnancy rates after clomiphene citrate andintrauterine insemination”The 59th

Annual meeting of the American Society for Reproductive Medicine: October 11-15,2003 SanAntonio, Texas.

15 / 25

CV N. Vlachos

21)          Wyncott D, Vlahos NP, Garcia JE, Zacur HA, Wallach EE, Zhao Y “ Intrauterineinsemination: which characteristics matter?The 59th

Annual meeting of the American Society for Reproductive Medicine: October 11-15,2003 SanAntonio, Texas.

22)          Whelan JG, III, Lawler A, Vlahos NP, Schamblott M, Gearhart J, Zacur HA. “Evidence for prolactin receptor in  human oocytes” The 59th

Annual meeting of the American Society for Reproductive Medicine: October 11-15,2003 SanAntonio, Texas.

23)               Bankowski B, Mavinkuvre G, Hammod A, King J, Zhao Y, Vlahos N. Bracero N. “The effect of Race on In Vitro Fertilization Success using a GnRH  antagonist protocol”District IV Annual meeting of the American College of Obstetricians and Gynecologists. Fajardo,Puerto Rico: October 15-19 2003.

24)               Bankowski B, Bracero N, Garcia  J, Wallach E, Vlahos N. “Triggering ovulationwith Leuprolide Acetate is associated with lower pregnancy rates.”20th

Annual meeting of the European Society for Reproduction and Embryology (ESHRE), June29-July 2nd

2004. Berlin Germany.

16 / 25

CV N. Vlachos

25)               Zhao Y, Lai T H, Shih I M, Ho C L, Vlahos  N “Expression of endometrial L-selectinligands at the implantation window” The 60th

Annual meeting of the American Society for Reproductive Medicine: October ,2004 Philadelphia PA.

26)               Lai TH, Shih I M, Vlahos N, Ho C L, Zhao Y “Differential expression of L-selectinligands in the endometrial epithelium during menstrual cycle” The 60th

Annual meeting of the American Society for Reproductive Medicine: October ,2004 Philadelphia PA.

27)               Vlahos N, Bankowski B, Lai T H, King J, Shih I M, Zhao Y. ”L-Selectin ligandexpression in the endometrium is not affected by luteal phase support” The 60th

Annual meeting of the American Society for Reproductive Medicine: October ,2004 Philadelphia PA.

28)               King J, Lai T, Vlahos, N, Bankowski B, Shih I, Wallach E, Zhao Y. “Expressionof syndican-1 in human endometrium following controlled ovarian hyperstimulationcompared to the natural cycle”.52nd

Annual meeting of the Society for Gynecologic Investigation, Los Angeles, CA, March   2005.

17 / 25

CV N. Vlachos

29)               Bankowski B.J, Gallicchio L.M, Lipari C.W., King J., Alexander C, Hammod A., Vlahos N. “Earlier decision making in IVF: Menstrual cycle day 6 hormones predict IVF outcome.”  Controversies in Obstetrics, Gynecology and Infertility: May 14-17 2005, Athens Greece.

30)               Stefanis P., Vlahos N., Grigoriou O., Botsis D., Gazvani R., Creastas G. “Relationbetween serum human chorionic gonadotropin levels ( hCG) and body mass index ( BMI)in women undergoing In Vitro Fertilization (IVF)” Controversies in Obstetrics, Gynecology and Infertility: May 14-17 2005, Athens Greece.

31)               Tzanakaki D., Baka S., Makrakis E., Vlahos N., Konidaris S., Hassiakos D. “Turner’s Syndrome and Reproduction”Controversies in Obstetrics, Gynecology and Infertility: May 14-17 2005, Athens Greece.

32)               Baka S., Tzanakaki D,. Makrakis E., Vlahos N., Konidaris S., Hassiakos D.,Creatsas G. “In vitro fertilization in poor responders: Results of natural cycles”Controversies in Obstetrics, Gynecology and Infertility: May 14-17 2005, Athens Greece.

33)               J. King, Tsung-Hsuan Lai, B. Bankowski, Y. Zhao, N. Vlahos, Ie-Ming Shih “Endometrial expression of syndecan-1 throughout the natural menstrual cycle” The 60th

Annual meeting of the American Society for Reproductive Medicine: October , 2005  MontrealCanada

18 / 25

CV N. Vlachos

Peer Reviewed Publications:

1)                   Pedanic, M., Vlahos, N.P., Pennisi, J.A., Moukhtar, M., Aleem, F.A. “Color andPulsed Doppler Sonography, Gray-scale Imaging, and Serum CA 125 in the Assessmentof Adnexal Disease.”Obstet. Gynecol. 1996; 88: 283-288.

2)                   Wallach, E.E., Vlahos, N.P. “The Mechanism of Mammalian Ovulation.” IsraelJ Obstet Gynecol 1998; 9: 127-31

3)                   Vlahos, N.P., Matthews, R., Veridiano, N. “Cervical Sarcoma Botryoides: CaseReport and Review of the Literature.”J. Reprod Med 1999; 44: 306-308.

19 / 25

CV N. Vlachos

4)                   Phelps, J.Y., Figeira-Armada, L., Levine, A.S., Vlahos, N.P., Rosanfekr, D.,Zacur, H.A., Garcia, J.E. “Exogenous Luteinizing Hormone (LH) Increases Estradiol Response Patterns in PoorResponders with Low Serum LH Concentrations.”J Assist Reprod Genet 1999; 7:363-8.

5)                   Whelan III, J., Vlahos, N.P.  “Review of the Ovarian HyperstimulationSyndrome.” Fertil Steril. 2000; 73(5);883-96

6)                   Vlahos, N.P., Dragisic, K.G., Wallach, E.E., Burroughs, F.H., Fluck, S.,Rosenthal, D.L . “Clinical Significance of Atypical SquamousCells of Undetermined Significance: An Analysis Based on Histologic Diagnosis.”Am J.Obstet Gynecol. 2000; 182 (4):885-90

7)                   Vlahos, N.P., Bugg, E.M., Shamblott, M.J., Phelps, J.Y. Garcia, J.E., Gearhart,J.D., Zacur, H.A. “Prolactin receptor gene expression andimmunolocalization of the prolactin receptor in luteinized human granulosa cells.”Mol. Hum. Reprod.2001;7 (10):1033-1038

8)                   Phelps, J.Y., Bugg, E.M., Shamblott, M.J., Vlahos, N.P., Whelan III J., Zacur, H.A.“Prolactin Gene

Expression in Human Ovarian Follicular Cells.”Fertil Steril 2003;79:182-9.

20 / 25

CV N. Vlachos

9)                   Jurema M, Vlahos NP., “ Un unusual complication of tubal reanastomosis” Fertil Steril 2003;79:624-627

10)               Posada N, Vlahos NP, Jurema M, Bracero N, Wallach EE, Garcia JE. “Clinicaloutcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetateprotocol in unselected women undergoing in vitro fertilization.”Fertil Steril. 2003 Jul; 80(1): 103-10.

11)               Vlahos N, Zeisset A. “Understanding pelvic adhesions. How to get up to datewith procedures, codes.”J AHIMA. 2003 May; 74(5): 74-7.

12)               Boyle K.E, Vlahos N, Jarow J.P. “Assisted reproductive rechnology in the newmillennium: part I.”

Urology. 2004 Jan;  63:2-6.

21 / 25

CV N. Vlachos

13)               Boyle K.E, Vlahos N, Jarow J.P. “Assisted reproductive technology in the newmillennium: part II.” Urology. 2004 Feb; 63(2):217-24.

14)               Zhao Y, Vlahos N, Wyncott D, Petrella C, Garcia J, Zacur H, Wallach EE. “Impactof semen characteristics on the success of intrauterine insemination.”J Assist Reprod Genet. 2004 May;21(5):143-8.

15)               Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinicalfeatures, and management.

Obstet Gynecol. 2004 Aug;104 (2):393-406.

16)               Vlahos NP, Bankowski BJ, Makrakis E. “ Non-puerperal uterine rupture afteruse of misoprostol and a Foley catheter for management of uterine bleeding.” Int J Gynaecol Obstet. 2005 Mar; 88(3):331-332.

17)                Vlahos NF, Coker L, Lawler C, Zhao Y, Bankowski B, Wallach EE.  “Women withovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate forintrauterine insemination may benefit from administration of human chorionicgonadotropin.”Fertil Steril. 2005 May;83(5):1510-6.

22 / 25

CV N. Vlachos

18)               Vlahos NF, Bankowski BJ, Zacur HA, Garcia JE, Wallach EE, Zhao Y.  “An oocytedonation protocol using the GnRH antagonist ganirelix acetate, does not compromiseembryo quality and is associated with high pregnancy rates.” Arch Gynecol Obstet. 2005 Apr 19;

19)               Lai TH, Shih IeM, Vlahos N, Ho CL, Wallach E, Zhao Y.  “Differential expressionof L-selectin ligand in the endometrium during the menstrual cycle.”Fertil Steril. 2005 Apr;83 Suppl 1:1297-302.

20)               Vlahos NF. Hysteroscopic resection of a large submucosal fibroid usingintermittent bimanual uterine massage and a bipolar resectoscope: a case report. J Reprod Med. 2005 Jul;50(7):543-6.

Reviews:

1)                   Vlahos, N.P., Garcia, J.E. “New Developments in Gonadotropin Therapy.”

23 / 25

CV N. Vlachos

Postgraduate Obstetrics and Gynecology.1997; 17: 24.

2)                   Vlahos, N.P., Phelps, J.Y., Wallach, E.E. “Chronic Pelvic Pain.” PostgraduateObstetrics and Gynecology 1998; 18:15.

3)                   Phelps, J.Y., Vlahos, N.P., Zacur, H.A.  “Diagnosis and ContemporaryManagement of Infertility.” PostgraduateObstetrics and Gynecology 1998; 18:13.

4)                   Vlahos, N.P., Sewell, C., Phelps, J.Y. “Gonadotropin Releasing HormoneAnalogs (Agonists and Antagonists).”Contemporary Obstetrics and Gynecology 1998; 43:83-93 (Cover-page article assigned forCME credits).

5)                   Wang, E.W., Vlahos, N.P.  “Selective Estrogen Receptor Modulators:Raloxifene.” Postgraduate Obstetrics and Gynecology1999; 19:10.

6)                   Vlahos, N.P., Zacur, H.A. “Hyperprolactinemia.” Resolve 1998; 23:4,1-7.

7)                   Vlahos, N.P., Zacur, H.A. “Menopause: An Overview.” Resolve 1998

8)                   Vlahos, N.P., Zacur, H.A.  “The Laboratory Approach to the Evaluation ofHirsutism.”  The Hopkins Medical Letter.

9)                   Vlahos, N.P., Zacur, H.A.  “Breastfeeding, Prolactin and Ovulation during thePuerperium.” The Endocrinologist, 1999; 451-456.

24 / 25

CV N. Vlachos

10)               Friedman YG, Vlahos NP. “Gonadotropin-Releasing Hormone Antagonists: Anew therapeutic modality.” Postgraduate Obstetricsand Gynecology 1999; 19:26.

11)               Parish Parker A, Vlahos NP. “Progesterone and Progestins: Physiologic role,preparations, and indications for therapy.” Postgraduate Obstetrics and Gynecology 1999; 20:6

12)               Wolfberg AJ, Vlahos N.P. “Transdermal estrogen replacement therapy”Postgraduate Obstetrics and Gynecology 2000;12:6.

13)               Jurema MW, Vlahos NP, Wallach EE. “Reproductive Health and CysticFibrosis” Postgraduate Obstetrics andGynecology 2001; 21:2

14)               Vlahos N. Giannakikou I. “Anesthesia in Assisted Reproductive Technology”Postgraduate Obstetrics and Gynecology 2003; 23:7

15)               Yates M, Vlahos N “ Endometriosis and In Vitro Fertilization” PostgraduateObstetrics and Gynecology 2003; 23:22

16)               Giannakikou I, Vlahos N, “΅Water intoxication syndrome in Gynecologicsurgery” Postgraduate Obstetrics and Gynecology,2004;24:23

17)               Vlahos N, Fortner K.  “ Emerging issues in endometriosis” PostgraduateObstetrics and Gynecology 2005; 25:4

25 / 25